Samuel D Riccitelli - Net Worth and Insider Trading

Samuel D Riccitelli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samuel D Riccitelli owns 4 companies in total, including Biocept Inc (BIOCQ) , OrthoPediatrics Corp (KIDS) , and Precipio Inc (PRPO) among others .

Click here to see the complete history of Samuel D Riccitelli’s form 4 insider trades.

Insider Ownership Summary of Samuel D Riccitelli

Ticker	Comapny	Transaction Date	Type of Owner
BIOCQ	Biocept Inc	2020-10-20	director
KIDS	OrthoPediatrics Corp	2017-12-14	director
PRPO	Precipio Inc	2017-09-26	director
		2015-11-19	director & President & CEO

Samuel D Riccitelli Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Samuel D Riccitelli Ownership Network

Ownership Network List of Samuel D Riccitelli

No Data

Ownership Network Relation of Samuel D Riccitelli

Samuel D Riccitelli Owned Company Details

What does Biocept Inc do?

Who are the key executives at Biocept Inc?

Samuel D Riccitelli is the director of Biocept Inc. Other key executives at Biocept Inc include VP & Controller Robert Walsh , Chief Operations Officer Philippe Marchand , and Sr. V.P. & General Counsel Darrell Taylor .

Biocept Inc (BIOCQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biocept Inc (BIOCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biocept Inc (BIOCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biocept Inc (BIOCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biocept Inc Insider Transactions

No Available Data

What does OrthoPediatrics Corp do?

Who are the key executives at OrthoPediatrics Corp?

Samuel D Riccitelli is the director of OrthoPediatrics Corp. Other key executives at OrthoPediatrics Corp include General Counsel and Secretary Daniel J Gerritzen , director & President and CEO Mark C Throdahl , and director & Chief Financial Officer Fred Hite .

OrthoPediatrics Corp (KIDS) Insider Trades Summary

Over the past 18 months, Samuel D Riccitelli made no insider transaction in OrthoPediatrics Corp (KIDS). Other recent insider transactions involving OrthoPediatrics Corp (KIDS) include a net sale of 7,573 shares made by Gregory A Odle , a net sale of 12,741 shares made by Daniel J Gerritzen , and a net sale of 7,551 shares made by Fred Hite .

In summary, during the past 3 months, insiders sold 10,000 shares of OrthoPediatrics Corp (KIDS) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 39,024 shares of OrthoPediatrics Corp (KIDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,024 shares.

OrthoPediatrics Corp (KIDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

OrthoPediatrics Corp Insider Transactions

No Available Data

What does Precipio Inc do?

Who are the key executives at Precipio Inc?

Samuel D Riccitelli is the director of Precipio Inc. Other key executives at Precipio Inc include Chief Operations Officer Ahmed Zaki Sabet , director & Chief Executive Officer Ilan Danieli , and Chief Financial Officer Matthew Gage .

Precipio Inc (PRPO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Precipio Inc (PRPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Precipio Inc (PRPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Precipio Inc (PRPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Precipio Inc Insider Transactions

No Available Data

What does Viridian Therapeutics Inc do?

Who are the key executives at Viridian Therapeutics Inc?

Samuel D Riccitelli is the director & President & CEO of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc , director & other: See Remarks Fairmount Healthcare Fund Gp Llc , and director & President and CEO Stephen F. Mahoney .

Viridian Therapeutics Inc (VRDN) Insider Trades Summary

Over the past 18 months, Samuel D Riccitelli made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 9,796 shares made by Lara Meisner , a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 1,600,000 shares, with a net purchase of 1,600,000 shares. During the past 18 months, 9,796 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,080,190 shares were bought by its insiders, resulting in a net purchase of 2,070,394 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viridian Therapeutics Inc Insider Transactions

No Available Data

Samuel D Riccitelli Mailing Address

Above is the net worth, insider trading, and ownership report for Samuel D Riccitelli. You might contact Samuel D Riccitelli via mailing address: 2850 Frontier Dr., Warsaw In 46582.

Discussions on Samuel D Riccitelli

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.